E-LIB Suche - Ergebnisse für: Outtier, An

1

Efficacy and Safety of Ustekinumab for Chronic Pouchitis: A..:

Outtier, An ; Louis, Edouard ; Dewit, Olivier...
Clinical Gastroenterology and Hepatology. , 2024

Link: https://doi.org/10.1016/..

2

P521 Effectiveness of ustekinumab as therapy for chronic an..:

Outtier, A ; Louis, E ; Dewit, O...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i649-i650 , 2023

Link: https://doi.org/10.1093/..

3

Tu1711 USTEKINUMAB AS INDUCTION AND MAINTENANCE THERAPY FOR..:

Outtier, An ; Louis, Edouard ; Dewit, Olivier...
Gastroenterology. 164 (2023) 6 - p. S-1089 , 2023

Link: https://doi.org/10.1016/..

4

P701 A time-to-event model relating infliximab trough conce..:

Kantasiripitak, W ; Outtier, A ; Thomas, D...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i833-i834 , 2023

Link: https://doi.org/10.1093/..

5

Analysis of Clinical Trial Screen Failures in Inflammatory ..:

Vieujean, Sophie ; Lindsay, James O ; D'Amico, Ferdinando...
Journal of Crohn's and Colitis. 18 (2023) 4 - p. 548-559 , 2023

Link: https://doi.org/10.1093/..

6

Tu1740 ANALYSIS OF CLINICAL TRIAL SCREEN FAILURES IN IBD: R..:

Vieujean, Sophie ; Lindsay, James O. ; Rubin, David T....
Gastroenterology. 164 (2023) 6 - p. S-1104 , 2023

Link: https://doi.org/10.1016/..

7

P664 Analysis of Clinical Trial Screen Failures in IBD: Rea..:

Vieujean, S ; Lindsay, J O ; Rubin, D...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i794-i797 , 2023

Link: https://doi.org/10.1093/..

8

Using provocative design to foster electronic informed cons..:

De Sutter, Evelien ; Verreydt, Stef ; Yskout, Koen...
BMC Medical Informatics and Decision Making. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

9

Mo1570: EFFECTIVENESS OF USTEKINUMAB AS INDUCTION THERAPY F..:

Outtier, An ; Louis, Edouard ; Dewit, Olivier...
Gastroenterology. 162 (2022) 7 - p. S-826 , 2022

Link: https://doi.org/10.1016/..

10

Longitudinal monitoring of STAT3 phosphorylation and histol..:

Verstockt, Bram ; Volk, Valery ; Jaeckel, Charlot...
Alimentary Pharmacology & Therapeutics. 56 (2022) 2 - p. 282-291 , 2022

Link: https://doi.org/10.1111/..

11

P533 Predictors of sustained remission after infliximab de-..:

Kantasiripitak, W ; Outtier, A ; Thomas, D...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i485-i486 , 2022

Link: https://doi.org/10.1093/..

12

P496 Efficacy and safety of ustekinumab for chronic antibio..:

Outtier, A ; Louis, E ; Dewit, O...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i460-i461 , 2022

Link: https://doi.org/10.1093/..

13

Multi‐model averaging improves the performance of model‐gui..:

Kantasiripitak, Wannee ; Outtier, An ; Wicha, Sebastian G....
CPT: Pharmacometrics & Systems Pharmacology. 11 (2022) 8 - p. 1045-1059 , 2022

Link: https://doi.org/10.1002/..

14

Screening Failure in a Large Clinical Trial Centre for Infl..:

Outtier, An ; Gijbels, Liese ; Noman, Maja...
Inflammatory Bowel Diseases. 29 (2022) 9 - p. 1440-1445 , 2022

Link: https://doi.org/10.1093/..

15

P333 Precise and unbiased infliximab dosing in patients wit..:

Kantasiripitak, W ; Outtier, A ; Thomas, D...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i350-i351 , 2022

Link: https://doi.org/10.1093/..